Williams RH, Maggiore JA, Reynolds RD, Helgason CM
10 In this study, BPC-157 showed a dose-dependent effect compared to the control during phase 1, but it showed little effect during phase 2
3.2 Treatment It is crucial to address the patient holistically by managing risks and triggers, rather than relying only on pharmacological treatments
Well-designed randomized clinical studies are needed to systematically evaluate the evidence for the use of these hepatoprotective agents as treatment options for APAP-induced liver injury, to determine the timing of initiation of the therapy, and to further define the optimal treatment regimen
Simple steatosis alone does not usually impair this storage function significantly
Some practitioners use it as part of combination approaches where its gentle mechanism complements more aggressive interventions